NVS Novartis ADR

For the fiscal year ended 31/12/2022: Novartis ADR's revenues decreased by 2.09% and amounted to 50.55B. Net income decreased by 71.04% to 6.96B. Net assets decreased by NaN to N/A and EPS decreased from 10.63 to N/A.